Recombinant Human GAL2 Protein，His

GAL2, or galactose-1-phosphate uridylyltransferase, is an essential enzyme in the galactose metabolism pathway, primarily involved in the conversion of galactose to glucose, a crucial process for energy production in organisms. Its dysfunction can lead to galactosemia, a genetic disorder characterized by an inability to metabolize galactose, resulting in severe health issues, including liver damage, developmental delays, and cognitive impairments. Studies have shown that the GAL2 protein exhibits distinct structural and functional properties that are critical for its enzymatic activity. Understanding these properties can provide insight into the molecular mechanisms underlying galactose metabolism and the pathophysiology of related disorders. Furthermore, the recombinant expression and purification of GAL2 can facilitate kinetic and structural studies, potentially leading to therapeutic advancements. Research on GAL2 not only contributes to the broader field of metabolic enzyme studies but also offers possibilities for designing targeted interventions and improving management strategies for individuals affected by galactosemia. In this context, characterizing GAL2 through recombinant protein techniques is crucial for elucidating its functional roles, enhancing our understanding of its interaction with other metabolic pathways, and paving the way for innovative approaches in clinical settings.